½ÃÀ庸°í¼­
»óǰÄÚµå
1769928

½º¸¶Æ® Àν¶¸° Ææ ¹× ÆßÇÁ ½ÃÀå : ¼¼°è »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ, ¿¹Ãø(2025-2035³â)

Smart Insulin Pens & Pumps Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025-2035

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Transparency Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 215 Pages | ¹è¼Û¾È³» : 2-10ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

½º¸¶Æ® Àν¶¸° Ææ ¹× ÆßÇÁ ½ÃÀå - ºÐ¼® ¹üÀ§

TMRÀÇ º¸°í¼­ "¼¼°è ½º¸¶Æ® Àν¶¸° Ææ ¹× ÆßÇÁ ½ÃÀå"Àº 2025³âºÎÅÍ 2035³â±îÁöÀÇ ¿¹Ãø ±â°£ µ¿¾È ½ÃÀå ÁöÇ¥¿¡ ´ëÇÑ ±ÍÁßÇÑ ÀλçÀÌÆ®¸¦ ¾ò±â À§ÇØ °ú°Å»Ó¸¸ ¾Æ´Ï¶ó ÇöÀçÀÇ ¼ºÀå µ¿Çâ°ú ±âȸ¸¦ Á¶»çÇϰí ÀÖ½À´Ï´Ù. ÀÌ º¸°í¼­´Â 2019³âºÎÅÍ 2035³â±îÁöÀÇ ¼¼°è ½º¸¶Æ® Àν¶¸° Ææ ¹× ÆßÇÁ ½ÃÀåÀÇ ¼öÀÍ ¹× ¿¹ÃøÀ» Á¦°øÇϴµ¥, 2025³âÀ» ±âÁØ ¿¬µµ·Î, 2035³âÀ» ¿¹Ãø ¿¬µµ·Î »ï°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, 2025³âºÎÅÍ 2035³â±îÁö ¼¼°è ½º¸¶Æ® Àν¶¸° Ææ ¹× ÆßÇÁ ½ÃÀåÀÇ ¿¬Æò±Õ ¼ºÀå·ü(CAGR, %)À» Á¦½ÃÇÕ´Ï´Ù.

ÀÌ º¸°í¼­´Â ±¤¹üÀ§ÇÑ Á¶»ç¸¦ ÅëÇØ ÀÛ¼ºµÇ¾ú½À´Ï´Ù. 1Â÷ Á¶»ç¿¡¼­´Â ¾Ö³Î¸®½ºÆ®°¡ ÁÖ¿ä ¿ÀÇǴϾ𠸮´õ, ¾÷°è ¸®´õ, ¿ÀÇǴϾð ¸ÞÀÌÄ¿¸¦ ´ë»óÀ¸·Î ÀÎÅͺ並 ½Ç½ÃÇß½À´Ï´Ù. 2Â÷ Á¶»ç¿¡¼­´Â ÁÖ¿ä ±â¾÷ÀÇ Á¦Ç° ÀÚ·á, ¿¬·Ê º¸°í¼­, º¸µµÀÚ·á, °ü·Ã ÀÚ·á µîÀ» ÂüÁ¶ÇÏ¿© ½º¸¶Æ® Àν¶¸° Ææ ¹× ÆßÇÁ ½ÃÀåÀ» Ãß·ÐÇÏ¿´½À´Ï´Ù.

½ÃÀå °³¿ä
½ÃÀå ±Ô¸ð(2024³â) 61¾ï ´Þ·¯
½ÃÀå ±Ô¸ð(2035³â) 146¾ï ´Þ·¯
CAGR 8.5%

ÀÌ º¸°í¼­´Â ¼¼°è ½º¸¶Æ® Àν¶¸° Ææ ¹× ÆßÇÁ ½ÃÀåÀÇ °æÀï ȯ°æÀ» ºÐ¼®ÇÕ´Ï´Ù. ¼¼°è ½º¸¶Æ® Àν¶¸° Ææ ¹× ÆßÇÁ ½ÃÀå¿¡¼­ Ȱµ¿ÇÏ´Â ÁÖ¿ä ¾÷ü¸¦ ½Äº°Çϰí, °¢ ¾÷ü´Â ´Ù¾çÇÑ ¼Ó¼ºº°·Î ÇÁ·ÎÆÄÀÏÀ» ÀÛ¼ºÇß½À´Ï´Ù. ±â¾÷ °³¿ä, À繫 »óÅÂ, Ãֽе¿Çâ, SWOT´Â º» º¸°í¼­¿¡¼­ ¼Ò°³ÇÏ´Â ¼¼°è ½º¸¶Æ® Àν¶¸° Ææ ¹× ÆßÇÁ ½ÃÀåÀÇ °¢ ±â¾÷ÀÇ ¼Ó¼ºÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå °¡Á¤°ú ºÐ¼® ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à : ¼¼°è ½ÃÀå

Á¦4Àå ½ÃÀå °³¿ä

  • ¼Ò°³
  • °³¿ä
  • ½ÃÀå ¿ªÇÐ
  • ¼¼°èÀÇ ½º¸¶Æ® Àν¶¸° Ææ ¹× ÆßÇÁ ½ÃÀå ºÐ¼®°ú ¿¹Ãø(2020-2035³â)

Á¦5Àå ÁÖ¿ä ÀλçÀÌÆ®

  • ±â¼úÀû Áøº¸
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
  • °ø±Þ¸Á ºÐ¼®
  • ÁÖ¿ä ¾÷°è À̺¥Æ®
  • ºê·£µå¿Í °¡°Ý ºÐ¼®
  • ÁÖ¿ä Áö¿ª/±¹°¡ÀÇ ±ÔÁ¦ »óȲ

Á¦6Àå ¼¼°è ½ÃÀå ºÐ¼®°ú ¿¹Ãø : Á¦Ç° Á¾·ùº°

  • ¼Ò°³¿Í Á¤ÀÇ
  • ÁÖ¿ä ºÐ¼® °á°ú/µ¿Çâ
  • ½ÃÀå ¿¹Ãø : Á¦Ç° Á¾·ùº°(±Ý¾× ±âÁØ, 2020-2035³â)
    • ½º¸¶Æ® Àν¶¸° Ææ
    • ½º¸¶Æ® Àν¶¸° ÆßÇÁ
  • ½ÃÀå ¸Å·Â ºÐ¼® : Á¦Ç° Á¾·ùº°

Á¦7Àå ¼¼°è ½ÃÀå ºÐ¼®°ú ¿¹Ãø : ÀûÀÀÁõº°

  • ¼Ò°³¿Í Á¤ÀÇ
  • ÁÖ¿ä ºÐ¼® °á°ú/µ¿Çâ
  • ½ÃÀå ¿¹Ãø : ÀûÀÀÁõº°(±Ý¾× ±âÁØ, 2020-2035³â)
    • 1Çü ´ç´¢º´
    • 2Çü ´ç´¢º´
  • ½ÃÀå ¸Å·Â ºÐ¼® : ÀûÀÀÁõº°

Á¦8Àå ¼¼°è ½ÃÀå ºÐ¼®°ú ¿¹Ãø : ÃÖÁ¾»ç¿ëÀÚº°

  • ¼Ò°³¿Í Á¤ÀÇ
  • ÁÖ¿ä ºÐ¼® °á°ú/µ¿Çâ
  • ½ÃÀå ¿¹Ãø : ÃÖÁ¾»ç¿ëÀÚº°(±Ý¾× ±âÁØ, 2020-2035³â)
    • º´¿ø¡¤Áø·á¼Ò
    • ÀçÅÃÀÇ·á
    • ±âŸ
  • ½ÃÀå ¸Å·Â ºÐ¼® : ÃÖÁ¾»ç¿ëÀÚº°

Á¦9Àå ¼¼°è ½ÃÀå ºÐ¼®°ú ¿¹Ãø : Áö¿ªº°

  • ÁÖ¿ä ºÐ¼® °á°ú
  • ½ÃÀå ¿¹Ãø : Áö¿ªº°(±Ý¾× ±âÁØ, 2020-2035³â)
    • ºÏ¹Ì
    • À¯·´
    • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ¶óƾ¾Æ¸Þ¸®Ä«
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
  • ½ÃÀå ¸Å·Â ºÐ¼® : Áö¿ªº°

Á¦10Àå ºÏ¹ÌÀÇ ½ÃÀå ºÐ¼®°ú ¿¹Ãø

Á¦11Àå À¯·´ÀÇ ½ÃÀå ºÐ¼®°ú ¿¹Ãø

Á¦12Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ½ÃÀå ºÐ¼®°ú ¿¹Ãø

Á¦13Àå ¶óÆ¾¾Æ¸Þ¸®Ä«ÀÇ ½ÃÀå ºÐ¼®°ú ¿¹Ãø

Á¦14Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ½ÃÀå ºÐ¼®°ú ¿¹Ãø

Á¦15Àå °æÀï ±¸µµ

  • ½ÃÀå ±â¾÷¡¤°æÀï ¸ÅÆ®¸¯½º(±â¾÷ °èÃþº°¡¤±Ô¸ðº°)
  • ½ÃÀå Á¡À¯À² ºÐ¼® : ±â¾÷º°(2024³â)
  • ±â¾÷ °³¿ä
    • Novo Nordisk A/S
    • Sanofi
    • Insulet Corporation
    • Medtronic
    • Abbott
    • Medtrum Technologies Inc.
    • Ypsomed
    • Jiangsu Delfu Medical Device Co. Ltd.
    • Tandem Diabetes Care, Inc.
    • SOOIL Developments Co., Ltd
ksm 25.07.22

Smart Insulin Pens & Pumps Market - Scope of Report

TMR's report on the global smart insulin pens & pumps market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2025 to 2035. The report provides revenue of the global smart insulin pens & pumps market for the period 2019-2035, considering 2025 as the base year and 2035 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global smart insulin pens & pumps market from 2025 to 2035.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the smart insulin pens & pumps market.

Market Snapshot
Market Value in 2024US$ 6.1 Bn
Market Value in 2035US$ 14.6 Bn
CAGR8.5%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global smart insulin pens & pumps market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global smart insulin pens & pumps market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global smart insulin pens & pumps market.

The report delves into the competitive landscape of the global smart insulin pens & pumps market. Key players operating in the global smart insulin pens & pumps market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global smart insulin pens & pumps market profiled in this report.

Key Questions Answered in Global smart insulin pens & pumps Market Report:

  • What is the sales/revenue generated by smart insulin pens & pumps across all regions during the forecast period?
  • What are the opportunities in the global smart insulin pens & pumps market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2035?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Smart Insulin Pens & Pumps Market - Research Objectives and Research Approach

The comprehensive report on the global smart insulin pens & pumps market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global smart insulin pens & pumps market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2035 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global smart insulin pens & pumps market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Smart Insulin Pens & Pumps Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Smart Insulin Pens & Pumps Market Analysis and Forecast, 2020 to 2035
    • 4.4.1. Market Revenue Projections (US$ Bn)

5. Key Insights

  • 5.1. Technological Advancements
  • 5.2. PORTER's Five Forces Analysis
  • 5.3. PESTLE Analysis
  • 5.4. Supply Chain Analysis
  • 5.5. Key Industry Events
  • 5.6. Brand and Pricing Analysis
  • 5.7. Regulatory Landscape across Key Regions / Countries

6. Global Smart Insulin Pens & Pumps Market Analysis and Forecast, by Product Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Product Type, 2020 to 2035
    • 6.3.1. Smart Insulin Pens
    • 6.3.2. Smart Insulin Pumps
  • 6.4. Market Attractiveness Analysis, by Product Type

7. Global Smart Insulin Pens & Pumps Market Analysis and Forecast, by Indication

  • 7.1. Introduction & Definition
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Indication, 2020 to 2035
    • 7.3.1. Type 1 Diabetes
    • 7.3.2. Type 2 Diabetes
  • 7.4. Market Attractiveness Analysis, by Indication

8. Global Smart Insulin Pens & Pumps Market Analysis and Forecast, by End-user

  • 8.1. Introduction & Definition
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by End-user, 2020 to 2035
    • 8.3.1. Hospitals and Clinics
    • 8.3.2. Homecare
    • 8.3.3. Others
  • 8.4. Market Attractiveness Analysis, by End-user

9. Global Smart Insulin Pens & Pumps Market Analysis and Forecast, by Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast, by Region, 2020 to 2035
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness Analysis, by Region

10. North America Smart Insulin Pens & Pumps Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast, by Product Type, 2020 to 2035
    • 10.2.1. Smart Insulin Pens
    • 10.2.2. Smart Insulin Pumps
  • 10.3. Market Value Forecast, by Indication, 2020 to 2035
    • 10.3.1. Type 1 Diabetes
    • 10.3.2. Type 2 Diabetes
  • 10.4. Market Value Forecast, by End-user, 2020 to 2035
    • 10.4.1. Hospitals and Clinics
    • 10.4.2. Homecare
    • 10.4.3. Others
  • 10.5. Market Value Forecast, by Country, 2020 to 2035
    • 10.5.1. U.S.
    • 10.5.2. Canada
  • 10.6. Market Attractiveness Analysis
    • 10.6.1. By Product Type
    • 10.6.2. By Indication
    • 10.6.3. By End-user
    • 10.6.4. By Country

11. Europe Smart Insulin Pens & Pumps Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Product Type, 2020 to 2035
    • 11.2.1. Smart Insulin Pens
    • 11.2.2. Smart Insulin Pumps
  • 11.3. Market Value Forecast, by Indication, 2020 to 2035
    • 11.3.1. Type 1 Diabetes
    • 11.3.2. Type 2 Diabetes
  • 11.4. Market Value Forecast, by End-user, 2020 to 2035
    • 11.4.1. Hospitals and Clinics
    • 11.4.2. Homecare
    • 11.4.3. Others
  • 11.5. Market Value Forecast, by Country/Sub-region, 2020 to 2035
    • 11.5.1. Germany
    • 11.5.2. UK
    • 11.5.3. France
    • 11.5.4. Italy
    • 11.5.5. Spain
    • 11.5.6. Rest of Europe
  • 11.6. Market Attractiveness Analysis
    • 11.6.1. By Product Type
    • 11.6.2. By Indication
    • 11.6.3. By End-user
    • 11.6.4. By Country/Sub-region

12. Asia Pacific Smart Insulin Pens & Pumps Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Product Type, 2020 to 2035
    • 12.2.1. Smart Insulin Pens
    • 12.2.2. Smart Insulin Pumps
  • 12.3. Market Value Forecast, by Indication, 2020 to 2035
    • 12.3.1. Type 1 Diabetes
    • 12.3.2. Type 2 Diabetes
  • 12.4. Market Value Forecast, by End-user, 2020 to 2035
    • 12.4.1. Hospitals and Clinics
    • 12.4.2. Homecare
    • 12.4.3. Others
  • 12.5. Market Value Forecast, by Country/Sub-region, 2020 to 2035
    • 12.5.1. China
    • 12.5.2. Japan
    • 12.5.3. India
    • 12.5.4. Australia & New Zealand
    • 12.5.5. Rest of Asia Pacific
  • 12.6. Market Attractiveness Analysis
    • 12.6.1. By Product Type
    • 12.6.2. By Indication
    • 12.6.3. By End-user
    • 12.6.4. By Country/Sub-region

13. Latin America Smart Insulin Pens & Pumps Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Product Type, 2020 to 2035
    • 13.2.1. Smart Insulin Pens
    • 13.2.2. Smart Insulin Pumps
  • 13.3. Market Value Forecast, by Indication, 2020 to 2035
    • 13.3.1. Type 1 Diabetes
    • 13.3.2. Type 2 Diabetes
  • 13.4. Market Value Forecast, by End-user, 2020 to 2035
    • 13.4.1. Hospitals and Clinics
    • 13.4.2. Homecare
    • 13.4.3. Others
  • 13.5. Market Value Forecast, by Country/Sub-region, 2020 to 2035
    • 13.5.1. Brazil
    • 13.5.2. Mexico
    • 13.5.3. Rest of Latin America
  • 13.6. Market Attractiveness Analysis
    • 13.6.1. By Product Type
    • 13.6.2. By Indication
    • 13.6.3. By End-user
    • 13.6.4. By Country/Sub-region

14. Middle East & Africa Smart Insulin Pens & Pumps Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Product Type, 2020 to 2035
    • 14.2.1. Smart Insulin Pens
    • 14.2.2. Smart Insulin Pumps
  • 14.3. Market Value Forecast, by Indication, 2020 to 2035
    • 14.3.1. Type 1 Diabetes
    • 14.3.2. Type 2 Diabetes
  • 14.4. Market Value Forecast, by End-user, 2020 to 2035
    • 14.4.1. Hospitals and Clinics
    • 14.4.2. Homecare
    • 14.4.3. Others
  • 14.5. Market Value Forecast, by Country/Sub-region, 2020 to 2035
    • 14.5.1. GCC Countries
    • 14.5.2. South Africa
    • 14.5.3. Rest of Middle East & Africa
  • 14.6. Market Attractiveness Analysis
    • 14.6.1. By Product Type
    • 14.6.2. By Indication
    • 14.6.3. By End-user
    • 14.6.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competition Matrix (By Tier and Size of Companies)
  • 15.2. Market Share Analysis, by Company (2024)
  • 15.3. Company Profiles
    • 15.3.1. Novo Nordisk A/S
      • 15.3.1.1. Company Overview
      • 15.3.1.2. Financial Overview
      • 15.3.1.3. Product Portfolio
      • 15.3.1.4. Business Strategies
      • 15.3.1.5. Recent Developments
    • 15.3.2. Sanofi
      • 15.3.2.1. Company Overview
      • 15.3.2.2. Financial Overview
      • 15.3.2.3. Product Portfolio
      • 15.3.2.4. Business Strategies
      • 15.3.2.5. Recent Developments
    • 15.3.3. Insulet Corporation
      • 15.3.3.1. Company Overview
      • 15.3.3.2. Financial Overview
      • 15.3.3.3. Product Portfolio
      • 15.3.3.4. Business Strategies
      • 15.3.3.5. Recent Developments
    • 15.3.4. Medtronic
      • 15.3.4.1. Company Overview
      • 15.3.4.2. Financial Overview
      • 15.3.4.3. Product Portfolio
      • 15.3.4.4. Business Strategies
      • 15.3.4.5. Recent Developments
    • 15.3.5. Abbott
      • 15.3.5.1. Company Overview
      • 15.3.5.2. Financial Overview
      • 15.3.5.3. Product Portfolio
      • 15.3.5.4. Business Strategies
      • 15.3.5.5. Recent Developments
    • 15.3.6. Medtrum Technologies Inc.
      • 15.3.6.1. Company Overview
      • 15.3.6.2. Financial Overview
      • 15.3.6.3. Product Portfolio
      • 15.3.6.4. Business Strategies
      • 15.3.6.5. Recent Developments
    • 15.3.7. Ypsomed
      • 15.3.7.1. Company Overview
      • 15.3.7.2. Financial Overview
      • 15.3.7.3. Product Portfolio
      • 15.3.7.4. Business Strategies
      • 15.3.7.5. Recent Developments
    • 15.3.8. Jiangsu Delfu Medical Device Co. Ltd.
      • 15.3.8.1. Company Overview
      • 15.3.8.2. Financial Overview
      • 15.3.8.3. Product Portfolio
      • 15.3.8.4. Business Strategies
      • 15.3.8.5. Recent Developments
    • 15.3.9. Tandem Diabetes Care, Inc.
      • 15.3.9.1. Company Overview
      • 15.3.9.2. Financial Overview
      • 15.3.9.3. Product Portfolio
      • 15.3.9.4. Business Strategies
      • 15.3.9.5. Recent Developments
    • 15.3.10. SOOIL Developments Co., Ltd
      • 15.3.10.1. Company Overview
      • 15.3.10.2. Financial Overview
      • 15.3.10.3. Product Portfolio
      • 15.3.10.4. Business Strategies
      • 15.3.10.5. Recent Developments
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦